Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026

Not intended for US and UK media New patient-reported outcomes data shows improved function and reduced symptom burden with HERNEXEOS® ...
The Lancet

Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind ...

aDepartment of Gastroenterology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China bDepartment of Gastroenterology, Shengjing Hospital of China Medical University ...

Haryana mandates CNG, EV fleets for aggregators in NCR districts

Chandigarh: In a major push for clean mobility and pollution control in the National Capital Region (NCR), the Haryana ...
Le Lézard

New Real-World Case Series Examines Re-Induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Clinical Practice

Ferring Pharmaceuticals today announced a new real-world case series demonstrating that re-induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) resulted in complete responses (CR) in ...